MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Statistics
Share Statistics
MAIA Biotechnology has 29.59M shares outstanding. The number of shares has increased by 19.79% in one year.
| Shares Outstanding | 29.59M |
| Shares Change (YoY) | 19.79% |
| Shares Change (QoQ) | 3.26% |
| Owned by Institutions (%) | 5.79% |
| Shares Floating | 21.55M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 737.42K, so 2.49% of the outstanding shares have been sold short.
| Short Interest | 737.42K |
| Short % of Shares Out | 2.49% |
| Short % of Float | 2.87% |
| Short Ratio (days to cover) | 4.69 |
Valuation Ratios
The PE ratio is -1.89 and the forward PE ratio is -2.3. MAIA Biotechnology's PEG ratio is 0.06.
| PE Ratio | -1.89 |
| Forward PE | -2.3 |
| PS Ratio | 0 |
| Forward PS | 0.7 |
| PB Ratio | 12.09 |
| P/FCF Ratio | -2.8 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MAIA Biotechnology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.
| Current Ratio | 2.65 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 297494.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.79M |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -19.39% in the last 52 weeks. The beta is 0.39, so MAIA Biotechnology's price volatility has been higher than the market average.
| Beta | 0.39 |
| 52-Week Price Change | -19.39% |
| 50-Day Moving Average | 1.68 |
| 200-Day Moving Average | 2.4 |
| Relative Strength Index (RSI) | 46.59 |
| Average Volume (20 Days) | 200.37K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -16.96M |
| Net Income | -23.25M |
| EBITDA | -16.96M |
| EBIT | -23.25M |
| Earnings Per Share (EPS) | -1.05 |
Balance Sheet
The company has 9.6M in cash and 0 in debt, giving a net cash position of 9.6M.
| Cash & Cash Equivalents | 9.6M |
| Total Debt | 0 |
| Net Cash | 9.6M |
| Retained Earnings | -87.23M |
| Total Assets | 10.16M |
| Working Capital | 6.32M |
Cash Flow
In the last 12 months, operating cash flow was -15.7M and capital expenditures 0, giving a free cash flow of -15.7M.
| Operating Cash Flow | -15.7M |
| Capital Expenditures | 0 |
| Free Cash Flow | -15.7M |
| FCF Per Share | -0.71 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MAIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for MAIA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -13.31 |
| Piotroski F-Score | 2 |